- Home
- LNTH vs ESAB Comparison
LNTH vs ESAB Comparison
Compare LNTH & ESAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- ESAB
- Stock Information
- Founded
- LNTH 1956
- ESAB 1904
- Country
- LNTH United States
- ESAB United States
- Employees
- LNTH N/A
- ESAB N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- ESAB Office Equipment/Supplies/Services
- Sector
- LNTH Health Care
- ESAB Industrials
- Exchange
- LNTH Nasdaq
- ESAB Nasdaq
- Market Cap
- LNTH 7.5B
- ESAB 6.9B
- IPO Year
- LNTH 2015
- ESAB N/A
- Fundamental
- Price
- LNTH $78.95
- ESAB $129.36
- Analyst Decision
- LNTH Strong Buy
- ESAB Buy
- Analyst Count
- LNTH 5
- ESAB 8
- Target Price
- LNTH $133.80
- ESAB $136.13
- AVG Volume (30 Days)
- LNTH 1.3M
- ESAB 268.9K
- Earning Date
- LNTH 05-07-2025
- ESAB 05-01-2025
- Dividend Yield
- LNTH N/A
- ESAB 0.31%
- EPS Growth
- LNTH N/A
- ESAB 16.34
- EPS
- LNTH 3.53
- ESAB 4.43
- Revenue
- LNTH $1,536,699,000.00
- ESAB $2,729,197,000.00
- Revenue This Year
- LNTH $5.81
- ESAB N/A
- Revenue Next Year
- LNTH $12.26
- ESAB $5.05
- P/E Ratio
- LNTH $22.69
- ESAB $29.31
- Revenue Growth
- LNTH 12.53
- ESAB N/A
- 52 Week Low
- LNTH $74.34
- ESAB $88.54
- 52 Week High
- LNTH $126.89
- ESAB $135.97
- Technical
- Relative Strength Index (RSI)
- LNTH 27.93
- ESAB 65.71
- Support Level
- LNTH $78.61
- ESAB $120.56
- Resistance Level
- LNTH $83.60
- ESAB $132.55
- Average True Range (ATR)
- LNTH 3.87
- ESAB 3.90
- MACD
- LNTH -3.13
- ESAB 1.26
- Stochastic Oscillator
- LNTH 1.12
- ESAB 82.47
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About ESAB ESAB Corporation
ESAB, spun off from Colfax in 2022, is a leading manufacturer of equipment and consumables used in welding, cutting, and joining applications. Alongside competitors Lincoln Electric and ITW's Miller brand, ESAB is one of the top three players in the welding space. ESAB generated roughly $2.7 billion in revenue in 2024.